Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations
- PMID: 15501397
- DOI: 10.1016/j.jaut.2004.07.005
Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations
Abstract
Dynamic interplay between cytokines and chemokines directs trafficking of peripheral blood mononuclear cells to tissues in autoimmune and/or viral diseases. The aim of the current study was to define the expression on CD3+ T cells of six chemokine receptors associated with inflammatory sites and the expression of intracellular cytokines, such as interferon-gamma (IFN-gamma) and interleukin-4 (IL-4), in Behcet's disease (BD). Flow cytometry was used to detect chemokine receptor and intracytoplasmic cytokines' expression. We observed that CD3+ T cells in the peripheral blood express a restricted array of inflammatory chemokine receptors, specifically, CCR5, CCR6 and CXCR3, but little CCR1-3. The highest expression of CXCR3 on CD3+ T cells is associated with the presence of central nervous system (CNS) manifestations or pulmonary involvement. CXCR3 is the principal inflammatory chemokine receptor involved in BD. CCR5 chemokine receptor is increased in BD regardless of clinical manifestations. The frequency of IFN-gamma-producing cells expressing CXCR3+ CD3+ cells is significantly increased in patients with BD compared with normal controls. IL-4-producing cells are decreased in BD. These results demonstrate the predominance of type 1 cytokine producing cells in CXCR3+ CD3+ T cells during BD. We hypothesize that CXCR3 is the principal inflammatory chemokine receptor involved in BD, particularly during CNS and pulmonary manifestations.
Similar articles
-
Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells.J Leukoc Biol. 2000 Oct;68(4):568-74. J Leukoc Biol. 2000. PMID: 11037980
-
Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.J Rheumatol. 1998 Feb;25(2):329-33. J Rheumatol. 1998. PMID: 9489829
-
Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.Br J Dermatol. 2006 Oct;155(4):722-8. doi: 10.1111/j.1365-2133.2006.07398.x. Br J Dermatol. 2006. PMID: 16965421
-
T cell chemokine receptor expression in human Th1- and Th2-associated diseases.Arch Immunol Ther Exp (Warsz). 2000;48(6):451-6. Arch Immunol Ther Exp (Warsz). 2000. PMID: 11197598 Review.
-
[Chemokines and chemokine receptors in multiple sclerosis].Nihon Rinsho. 2003 Aug;61(8):1422-7. Nihon Rinsho. 2003. PMID: 12962033 Review. Japanese.
Cited by
-
Immunopathogenesis of ocular Behçet's disease.J Immunol Res. 2014;2014:653539. doi: 10.1155/2014/653539. Epub 2014 Jul 2. J Immunol Res. 2014. PMID: 25061613 Free PMC article. Review.
-
Understanding Behçet's Disease in the Context of Innate Immunity Activation.Front Immunol. 2020 Oct 20;11:586558. doi: 10.3389/fimmu.2020.586558. eCollection 2020. Front Immunol. 2020. PMID: 33193413 Free PMC article. Review.
-
The role of CCR1 and therapeutic effects of anti-CCL3 antibody in herpes simplex virus-induced Behçet's disease mouse model.Immunology. 2019 Nov;158(3):206-218. doi: 10.1111/imm.13102. Epub 2019 Sep 8. Immunology. 2019. PMID: 31393598 Free PMC article.
-
Pharmacological Inactivation of Src Family Kinases Inhibits LPS-Induced TNF-α Production in PBMC of Patients with Behçet's Disease.Mediators Inflamm. 2016;2016:5414369. doi: 10.1155/2016/5414369. Epub 2016 Jun 30. Mediators Inflamm. 2016. PMID: 27445436 Free PMC article.
-
Regulating the Polarization of Macrophages: A Promising Approach to Vascular Dermatosis.J Immunol Res. 2020 Jul 28;2020:8148272. doi: 10.1155/2020/8148272. eCollection 2020. J Immunol Res. 2020. PMID: 32775470 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical